€207.20
0.19% day before yesterday
Paris, Oct 31, 05:35 pm CET
ISIN
FR0013154002
Symbol
DIM

Sartorius Stedim Biotech Stock price

€207.20
+35.15 20.43% 1M
+1.00 0.49% 6M
+18.50 9.80% YTD
+23.90 13.04% 1Y
-114.00 35.49% 3Y
-120.00 36.67% 5Y
+153.45 285.49% 10Y
+203.53 5,550.86% 20Y
Paris, Closing price Fri, Oct 31 2025
+0.40 0.19%

Key metrics

Basic
Market capitalization
€20.1b
Enterprise Value
€22.4b
Net debt
€2.2b
Cash
€338.2m
Shares outstanding
97.3m
Valuation (TTM | estimate)
P/E
76.7 | 46.4
P/S
6.8 | 6.6
EV/Sales
7.6 | 7.3
EV/FCF
59.7
P/B
5.0
Dividends
DPS
€0.69
Yield 1Y | 5Y
0.3% | 0.3%
Growth 1Y | 5Y
0.0% | 15.2%
Payout 1Y | 3Y
38.1% | 19.2%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€2.9b | €3.0b
EBITDA
€804.8m | €911.9m
EBIT
€490.0m | €636.4m
Net Income
€264.1m | €434.6m
Free Cash Flow
€374.5m
Growth (TTM | estimate)
Revenue
7.7% | 9.5%
EBITDA
19.4% | 30.4%
EBIT
25.5% | 60.0%
Net Income
56.3% | 148.2%
Free Cash Flow
-25.6%
Margin (TTM | estimate)
Gross
45.6%
EBITDA
27.3% | 30.0%
EBIT
16.6%
Net
9.0% | 14.3%
Free Cash Flow
12.7%
Financial Health
Equity Ratio
48.3%
Return on Equity
4.4%
ROCE
7.5%
ROIC
5.6%
Debt/Equity
0.6
More
EPS
€2.7
FCF per Share
€3.8
Short interest
-
Employees
10k
Rev per Employee
€280.0k
Show more

Is Sartorius Stedim Biotech a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Sartorius Stedim Biotech Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Sartorius Stedim Biotech forecast:

15x Buy
83%
3x Hold
17%

Analyst Opinions

18 Analysts have issued a Sartorius Stedim Biotech forecast:

Buy
83%
Hold
17%

Financial data from Sartorius Stedim Biotech

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,947 2,947
8% 8%
100%
- Direct Costs 1,602 1,602
1% 1%
54%
1,345 1,345
18% 18%
46%
- Selling and Administrative Expenses 665 665
3% 3%
23%
- Research and Development Expense 139 139
4% 4%
5%
805 805
19% 19%
27%
- Depreciation and Amortization 315 315
11% 11%
11%
EBIT (Operating Income) EBIT 490 490
26% 26%
17%
Net Profit 264 264
56% 56%
9%

In millions EUR.

Don't miss a Thing! We will send you all news about Sartorius Stedim Biotech directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sartorius Stedim Biotech Stock News

AD HOC NEWS
18 days ago
Sartorius Stedim Biotech SA / FR0013154002
AD HOC NEWS
18 days ago
Sartorius Stedim Biotech SA / FR0013154002
AD HOC NEWS
3 months ago
Sartorius Stedim Biotech SA / FR0013154002
More Sartorius Stedim Biotech News

Company Profile

Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions and focus on single-use technologies are supporting biopharma companies around the world to develop and produce drugs safely, timely and economically. The company's product portfolio include cell analysis, cell culture media and buffers, bioreactors fermenters, lab filtration & purification, process filtration & purification, fluid management, process control & data analytics, industrial microbiology, water purification, weighing, pipetting & dispensing OEM, centrifuges and lab catalogs. Sartorius Stedim Biotech was founded in 1978 and is headquartered in Aubagne, France.

Head office France
CEO René Fáber
Employees 9,961
Founded 1978
Website www.sartorius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today